Shenyang Dashan Pharmaceutical Technology

Shenyang Dasan Pharmaceutical Technology Co., Ltd. is a high-tech pharmaceutical company established in July 2014 and based in Shenyang, China. In August 2020, the company received a strategic investment from South Korea's Dasan Pharmaceutical, becoming a Sino-Korean joint venture. The company focuses on the development and industrialization of oral complex preparations using advanced drug delivery systems (DDS). It has established multiple technology platforms, including a powder coating taste masking platform and a sustained and controlled-release pellet development platform, primarily targeting formulations for children and the elderly. Additionally, the company operates as a contract research organization (CRO), providing services such as pharmaceutical preparation development, prescription optimization, generic drug consistency evaluation, and clinical trial registration for domestic and international clients.